Response Assessment Criteria and Their Applications in Lymphoma: Part 2.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 27879369.
- Also identified by DOI 10.2967/jnumed.116.184242.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Interim and end-of-treatment PET/CT have become central to the evaluation of Hodgkin and non-Hodgkin lymphoma. This review article seeks to aid clinical decision making by providing an overview of available data on the diagnostic and prognostic value of PET/CT imaging for response assessment and pretransplant evaluation in lymphoma. The relative strengths and limitations of these techniques in various disease subtypes and clinical scenarios are explored, along with their current standards for reporting and latest developments. Particular attention is given to response-adapted therapy, which is emerging as a cornerstone of clinical management.
Medical subject headings
- Decision Support Systems, Clinical
- Image Interpretation, Computer-Assisted
- Lymphoma
- Outcome Assessment, Health Care
- Positron Emission Tomography Computed Tomography